Results 111 to 120 of about 4,227 (136)

Clinical outcomes and prognostic factors in patients with nasolacrimal duct obstruction or stenosis using dacryoendoscopy. [PDF]

BMJ Open Ophthalmol
Li H, Li J, Zhang L, Yang L, Zhao Y, Zhao H, Pan Y.   +6 more
europepmc   +1 more source

Risk of primary acquired nasolacrimal duct obstruction among gastroesophageal reflux disease patients: a global population-based study. [PDF]

Eye (Lond)
Chu YY, Ho CH, Chen YC, Kuo SC, Lee PY, Lin YS.   +5 more
europepmc   +1 more source

Surgical outcomes of external dacryocystorhinostomy with flap versus without flap in acquired nasolacrimal duct obstruction. [PDF]

Indian J Ophthalmol
Kumar SV, Kumar V, Kumar NV, Sati A, Mishra SK, Bandopadhyay S.   +5 more
europepmc   +1 more source

Role of paranasal abnormalities and systemic inflammation on primary acquired nasolacrimal duct obstruction. [PDF]

J Ophthalmic Inflamm Infect
Sevimli N, Aydın Kurna S, Çakır M, Akkaya S.   +3 more
europepmc   +1 more source

Probing and nasolacrimal intubation outcomes in children over 18 Months of age with congenital nasolacrimal duct obstruction. [PDF]

Heliyon
Jafarizadeh A, Manouchehri V, Sobhi N, Mousavi F, Tondro Anamag F.   +4 more
europepmc   +1 more source

Relation between mode of delivery and related factors with congenital nasolacrimal duct obstruction. [PDF]

Saudi J Ophthalmol
Eshraghi B, Houshang-Jahromi MH, Haghshenas Z, Pourazizi M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)

Progress in Retinal and Eye Research, 2023
Mohammad Javed Ali
exaly  

Nasolacrimal duct obstruction as an important cause of epiphora

Disease-a-Month, 2020
Paul Owen Phelps
exaly  

Treatment of Congenital Nasolacrimal Duct Obstruction

American Orthoptic Journal, 1999
Malcolm L Mazow
exaly